Gloría Pérez-Rubio
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 14
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 22
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 19
- Physiology top 10%
- Smoking Behavior and Cessation 15
- Asthma and respiratory diseases 11
- Emergency Medical Services top 5%
- Pediatric health and respiratory diseases 10
-
- Long-Term Effects of COVID-19 10
-
- Inflammasome and immune disorders 8
- Co-authors
- Ramcés Falfán‐ValenciaAlejandra Ramírez‐VenegasIvette Buendía-RoldánEnrique Ambrocio-OrtizRaúl H. SansoresRafael de Jesús Hernández-ZentenoMayra MejíaÁngel Camarena
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Scientific Reports (1 paper)
- Partner nations
- MexicoUnited StatesSpain
In The Last Decade
Gloría Pérez-Rubio
89 papers receiving 870 citations
Peers
Comparison fields: 5 of 99
- Infectious Diseases 172
- Pulmonary and Respiratory Medicine 300
- Physiology 236
- Emergency Medical Services 60
- Immunology 142
Countries citing papers authored by Gloría Pérez-Rubio
This map shows the geographic impact of Gloría Pérez-Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloría Pérez-Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloría Pérez-Rubio more than expected).
Fields of papers citing papers by Gloría Pérez-Rubio
This network shows the impact of papers produced by Gloría Pérez-Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloría Pérez-Rubio. The network helps show where Gloría Pérez-Rubio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gloría Pérez-Rubio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 20 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 0 | |
| 15 | 2021 | 41 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 21 | |
| 18 | 2020 | 6 | |
| 19 | TNF promoter polymorphisms are associated with genetic susceptibility in COPD secondary to tobacco smoking and biomass burning | 2018 | 2 |
| 20 | Bases genéticas y moleculares de alfa-1 antitripsina (SERPINA1) y su papel en la EPOC | 2009 | 2 |
About Gloría Pérez-Rubio
Gloría Pérez-Rubio is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Physiology, having authored 100 papers that have together received 880 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Smoking Behavior and Cessation (15 papers), COVID-19 Clinical Research Studies (14 papers), Asthma and respiratory diseases (11 papers), Pediatric health and respiratory diseases (10 papers), Long-Term Effects of COVID-19 (10 papers) and Inflammasome and immune disorders (8 papers). The work is most often cited by research in Infectious Diseases (172 citations), Pulmonary and Respiratory Medicine (300 citations) and Physiology (236 citations). Gloría Pérez-Rubio has collaborated with scholars based in Mexico, United States and Spain. Frequent co-authors include Ramcés Falfán‐Valencia, Alejandra Ramírez‐Venegas, Ivette Buendía-Roldán, Enrique Ambrocio-Ortiz, Raúl H. Sansores, Rafael de Jesús Hernández-Zenteno, Mayra Mejía, Ángel Camarena, Jorge Rojas‐Serrano and Leslie Chávez‐Galán. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.